Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | JAK3 | P52333 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL345810 | 1.00 | KDM4E (0.37) | KDM4EL3MBTL1ATMNPSR1MEN1 | |
| SCHEMBL801440 | 1.00 | KDM4E (0.37) | KDM4EL3MBTL1ATMNPSR1MEN1 | |
| SCHEMBL801432 | 0.97 | NPSR1 (0.34) | KDM4EL3MBTL1ATMNPSR1MEN1 | |
| SCHEMBL801102 | 0.97 | NPSR1 (0.34) | KDM4EL3MBTL1ATMNPSR1MEN1 | |
| SCHEMBL801300 | 0.95 | NPSR1 (0.35) | KDM4EL3MBTL1ATMNPSR1MEN1 | |
| SCHEMBL12879596 | 0.95 | NPSR1 (0.35) | KDM4EL3MBTL1ATMNPSR1JAK2 | |
| SCHEMBL17562120 | 0.94 | NPSR1 (0.33) | KDM4EL3MBTL1ATMNPSR1MEN1 | |
| SCHEMBL801099 | 0.91 | KDM4E (0.42) | KDM4EL3MBTL1ATMNPSR1MEN1 | |
| SCHEMBL22695385 | 0.91 | NPSR1 (0.32) | KDM4EL3MBTL1ATMNPSR1MEN1 | |
| SCHEMBL801191 | 0.90 | NPSR1 (0.36) | KDM4EL3MBTL1NPSR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2023-01-26 | — | — | US | disclosed |
| US-20220144869-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | UDC IRELAND LIMITED (IE) | 2022-05-12 | — | — | US | disclosed |
| US-11189806-B2 | Heteroleptic carbene complexes and the use thereof in organic electronics | UDC IRELAND LIMITED (IE) | 2021-11-30 | — | — | US | disclosed |
| US-20210126207-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2021-04-29 | — | — | US | disclosed |
| US-10916716-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2021-02-09 | — | — | US | disclosed |
| US-20200373503-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2020-11-26 | — | — | US | disclosed |
| EP-2393819-B9 | SILYL AND HETEROATOM SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZO PHOSPHOLES AND THE APPLICATION THEREOF IN ORGANIC ELECTRONICS | UDC IRELAND LTD (IE) | 2017-12-27 | — | — | EP | disclosed |
| US-20170025626-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2017-01-26 | — | — | US | disclosed |
| EP-2651904-B1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2014-11-12 | — | — | EP | disclosed |
| US-8691401-B2 | Bridged benzimidazole-carbene complexes and use thereof in OLEDS | BASF SE (DE) | 2014-04-08 | — | — | US | disclosed |
| US-8691401-B2 | Bridged benzimidazole-carbene complexes and use thereof in OLEDS | BASF SE (DE) | 2014-04-08 | — | — | US | disclosed |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2013-02-07 | — | — | US | disclosed |
| US-8362246-B2 | Bispyrimidines for electronic applications | BASF SE (DE) | 2013-01-29 | — | — | US | disclosed |
| US-20120205645-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2012-08-16 | — | — | US | disclosed |
| US-20120149904-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-06-14 | — | — | US | disclosed |
| US-20120068168-A1 | CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) | 2012-03-22 | — | — | US | disclosed |
| US-20120012821-A1 | SILYL- AND HETEROATOM-SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZOPHOSPHOLES, AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2012-01-19 | — | — | US | disclosed |
| US-20110253988-A1 | BRIDGED BENZIMIDAZOLE-CARBENE COMPLEXES AND USE THEREOF IN OLEDS | BASF SE (DE) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120205645-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | OCIAD2, OCIAD1, CLTB | KDM4E 3813/4885L3MBTL1 1656/4885ATM 4500/4885 |
| US-20120149904-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | DPYD, TYMP, TYMS | KDM4E 1622/4885L3MBTL1 3766/4885ATM 2950/4885 |
| US-20220144869-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | OCIAD2, OCIAD1, CLTB | KDM4E 4143/4885L3MBTL1 1926/4885ATM 4604/4885 |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | OCIAD1, OCIAD2, DRD2 | KDM4E 4587/4885L3MBTL1 2826/4885ATM 3382/4885 |
| US-20110253988-A1 | BRIDGED BENZIMIDAZOLE-CARBENE COMPLEXES AND USE THEREOF IN OLEDS | CCND1, DRD2, CCND2 | KDM4E 3589/4885L3MBTL1 1507/4885ATM 3853/4885 |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | KDM4E 4573/4885L3MBTL1 2835/4885ATM 3351/4885 |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | KDM4E 4573/4885L3MBTL1 2835/4885ATM 3351/4885 |
| US-20120068168-A1 | CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | INPP5B, EZH2, PLCB3 | KDM4E 1186/4885L3MBTL1 1822/4885ATM 3758/4885 |
| US-20210126207-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | KDM4E 4573/4885L3MBTL1 2835/4885ATM 3351/4885 |
| US-20170025626-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | KDM4E 4573/4885L3MBTL1 2835/4885ATM 3351/4885 |
| US-20200373503-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | OCIAD2, OCIAD1, CLTB | KDM4E 3813/4885L3MBTL1 1656/4885ATM 4500/4885 |
| US-11189806-B2 | Heteroleptic carbene complexes and the use thereof in organic electronics | OCIAD2, OCIAD1, CLTB | KDM4E 3813/4885L3MBTL1 1656/4885ATM 4500/4885 |
| US-20120012821-A1 | SILYL- AND HETEROATOM-SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZOPHOSPHOLES, AND USE THEREOF IN ORGANIC ELECTRONICS | DDT, CDKL1, CDK2 | KDM4E 2857/4885L3MBTL1 198/4885ATM 3045/4885 |
| US-10916716-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | KDM4E 4573/4885L3MBTL1 2835/4885ATM 3351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.